granulocyte antibodies in the nodular sclerosing and lymphocyte depleted subtypes. ReedStemnberg cells in all but three cases of mixed cellularity Hodgkin's disease were positive with both Leu-M1 and 3C4. One case stained with only Leu-M1, and two cases were consistently negative with both antibodies. HLA-DR was widely expressed in the Reed-Stemnberg cells of all three subtypes. In the four cases of lymphocyte predominant Hodgkin's disease the multinucleated Reed-Stemnberg cells did not stain with either antigranulocyte antibody but were strongly positive with anti-HLA-DR. Twenty five cases of non-Hodgkin's lymphoma, in which there were multinucleated giant cells resembling Reed-Stemnberg cells, were studied in a similar way. These cases included pleomorphic T cell and B cell lymphomas, histiocytic lymphomas, and malignant histiocytosis of the intestine. In none of these did the multinucleated cells stain with either antigranulocyte antibody, but in most cases the multinucleated cells stained with anti-HLA-DR.
In two cases of the tumour stage of mycosis fungoides dot like intracytoplasmic staining was shown in the tumour cells with both antigranulocyte markers. The monoclonal antigranulocyte antibodies Leu-M1 and 3C4 are of considerable value in both the diagnosis and the differential diagnosis of Hodgkin's disease and are particularly valuable in that they can be applied to tissue fixed in formalin and embedded in paraffin. Antibody to HLA-DR, while useful, is of less value.
The histological diagnosis of Hodgkin' s disease may not always be straightforward. The classical cellular subtypes may be mimicked by reactive lymphoid proliferations' 2 and the non-Hodgkin's lymphomas. 25 July 1985 and their mononuclear counterparts. Stein and coworkers used a range of granulocyte specific markers.8 The most effective for staining ReedStemnberg cells were the reagents TU-9 and 3C4.9 The same group described a monoclonal antibody, Ki-1, as a specific marker of Reed-Stemnberg cells and a subset of small lymphocytes.' "1 This antibody, however, is effective only in fresh frozen tissue. Other workers found the granulocyte specific monoclonal antibody Leu-M1 to be an effective marker of Reed-Stemnberg and Hodgkin cells. '2-15 The presence of HLA-D region antigens on Reed-Sternberg cells has been shown in cell culture and frozen tissue. ' Leu-M1+/3C4 not done (Fig.  2b) . By contrast, HLA-DR was strongly expressed in these cells (Fig. 2c) .
MIXED CELLULARITY HODGKIN'S DISEASE
The Reed-Sternberg cells in nine cases of mixed cellularity Hodgkin's disease stained with both antigranulocyte antibodies. Notably, one case marked only with Leu-M1 and two cases were consistently negative with both antibodies, even in cryostat cut sections. The expression of HLA-DR in these cases varied depending on fixation. Twelve cases gave positive staining with TAL-IB5. The negative cases had been fixed for a prolonged period in unbuffered formol saline.
NODULAR SCLEROSING HODGKIN'S DISEASE
Reed-Sternberg cells in 11 of 12 cases of nodular sclerosing Hodgkin's disease stained with both antigranulocyte antibodies (Fig. lb) . One case stained only with the antibody 3C4. Expression of HLA-DR was present in 10 cases (Fig. lc) . Those that were negative had been adversely fixed.
Norton, Isaacson LYMPHOCYTE DEPLETED HODGKIN'S DISEASE
In two cases of lymphocyte depleted Hodgkin's disease the Reed-Sternberg cells stained with the antigranulocyte markers. HLA-DR was present in both cases. Table 3 summarises the immunocytochemical staining results. B cell lymphomas Four cases of pleomorphic B cell lymphoma (Fig. 3a) and one case of B immunoblastic lymphoma were consistently negative with the antigranulocyte antibodies (Fig.  3b) . Granular intracytoplasmic HLA-DR was consistently found in the giant cells (Fig. 3c) The presence of giant cells resembling ReedSternberg cells in both B6 and T cell4 5 lymphomas can present difficulties in distinguishing these conditions from Hodgkin's disease. We have clearly shown that in such cases the antigranulocyte anti-bodies Leu-M1 and 3C4 are useful discriminants. In two cases of the tumour stage of mycosis fungoides positive staining could be shown in the small and medium sized lymphocytes. The distribution was cytoplasmic and dot like in both cases. The finding of positive staining in cutaneous T cell tumours was not unexpected as activated T helper cells express the Leu-M1 antigen by immunofluorescence. 24 Recently, another group claimed to have stained T cell lymphomas with Leu-M1. 27 Apart from cutaneous tumours, this has not been our experience with this antibody. In spite of this finding, as long as the strict criteria for the staining of Reed-Sternberg cells are observed, there should be no confusion with the occasionally positive T cell tumour. An additional useful distinguishing feature in these cases was the lack of HLA-DR expression in the antigranulocyte positive T cell lymphomas.
NON-HODGKIN'S LYMPHOMAS
With the exception of the lymphocyte predominant subtype the antigranulocyte antibodies were of great value in diagnosing Hodgkin's disease. These antibodies have the advantages of tissue specificity and flexibility over Ki-1. Our findings indicate that it is desirable to use more than one antigranulocyte antibody in cases of diagnostic difficulty. In those cases in which Reed-Sternberg cells fail to mark with either marker the diagnosis of Hodgkin's disease should be in doubt. In such instances strict morphological criteria should be applied and supportive immunocytochemistry should be undertaken before the disease is diagnosed. We thank K Miller, S Cotterill, and Sharon Law for their excellent technical help.
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